市场调查报告书
商品编码
1284230
到 2028 年的患者监护市场预测——按设备类型、应用、最终用户和地区进行的全球分析Patient Monitoring Market Forecasts to 2028 - Global Analysis By Device Type, Application, End User and By Geography |
据 Stratistics MRC 预计,到 2022 年,全球患者监护市场将达到 423 亿美元,预测期内以 9.1% 的复合年增长率增长,到 2028 年将达到 713.3 亿美元。
患者监测系统是医疗保健专业人员监测患者健康的一系列工具。 这些设备,也称为远程生理监测,经常用于远程患者监测。 一组仪器和机器,用于跟踪和记录患者健康状况的变化,同时使用各种生命体征和警报系统持续监测患者。 患者不再需要经常去看医生,仅此一项就可以省钱。 它还可以对患者护理计划进行适当调整,并增强数据驱动的临床决策。
根据世界卫生组织 (WHO) 的数据,全世界约有 4.22 亿人患有糖尿病,约 2.35 亿人患有哮喘。
现有医疗保健系统的可持续性是世界各国政府的主要关注点。 由于医疗费用的增加,尤其是在医院,重点是替代疗法,如家庭护理。 远程监控和家庭监控设备的使用增加显着减少了再入院率。 对胎儿和新生儿监护仪、温度监护仪、脉搏血氧仪、EEG 记录仪、事件和 ECG 监护仪等有效家庭技术的需求不断增长,这推动了市场需求。
降低医疗保健成本的国际努力包括价格监管、竞争性定价、招标和合同程序、保险范围和支付政策、药物疗效比较、技术评估和管理式医疗系统。有。 税收预计将推高运营成本,并对全球主要医疗保健市场的医疗器械业务的现金流产生不利影响。
可穿戴患者监测设备的应用包括连续血糖监测、温度监测、血压监测和脉搏血氧仪。 物联网可用于新一代可穿戴技术。 随着无线数据传输网络变得更好和更广泛可用,用于远程医疗和更好的患者监控的平台将变得更容易设计。 可穿戴生物传感器的增加推动了市场需求。
有缺陷的硬件或糟糕的规划可能会导致系统失败,因此拥有一种预测和解决系统故障的方法非常重要。 特别是,对于安全关键型应用,例如与人类健康相关的患者监护设备,有关係统故障的风险分析应被视为必不可少的。 这一点威胁到对产品的需求。
在 COVID-19 大流行期间,世界各地都实行了社会隔离和检疫措施。 因此,许多人避免了频繁去医院就诊。 因此,每天检测家中的温度和氧气浓度,掌握健康状况就变得清晰起来。 可穿戴技术可以通过整合临床症状和生命指标来帮助识别许多慢性疾病。 因此,使用可穿戴技术来对抗 COVID-19 的情况急剧增加。
据估计,血糖监测设备领域将实现利润丰厚的增长。 血糖监测装置包括自我监测和连续监测装置。 糖尿病患病率和患病率的增加,以及新产品的推出和发展中国家血糖监测设备使用的增加,预计将推动这一领域的扩张。
在预测期内,医院和诊所部门预计将以最快的复合年增长率增长。 许多患者群体更喜欢医院和诊所,尤其是在新兴国家。 此外,在医院进行的手术数量不断增加,以及医院为引进高科技患者监护设备提供的资金支持,也为市场占有很大份额做出了贡献。
由于传染病数量庞大,亚太地区预计在预测期内将占据最大的市场份额。 该地区老年人口众多,许多公营和私营公司都在大力投资医疗保健基础设施。 医院基础设施的扩建和门诊手术中心的增加也有望推动亚太地区的市场。
预计北美在预测期内的复合年增长率最高。 慢性病的发病率和流行率在北美急剧增加。 北美是 GE Healthcare、Edward Lifesciences、Masimo Corporation 和 Natus Medical 等主要製造商的所在地。 这些製造商正在投资研发和建造设施,以生产更现代的患者监护设备。 人口增长和降低医疗成本的需求增加推动了这一领域的市场扩张。
2022 年 9 月,全球领先的医疗技术、诊断和数字解决方案创新者 GE Healthcare 将推出首款“印度製造”、“人工智能驱动”的产品,以推进印度的心臟护理。宣布推出 Catlab -Optima IGS 320。
2022 年 7 月,强生消费者健康部宣布推出经环境工作组 (EWG) 认证的婴儿护肤和护髮品牌 Vivvi & Bloom。 该品牌是与千禧一代和 Gen-Z 的父母和看护人社区共同创建的,名为“The Village”,集思广益他们想要什么。
2022 年 4 月,飞利浦医疗推出了配备先进声波技术的飞利浦 Sonicare 系列电动牙刷的新产品。 它去除牙菌斑的效果是手动牙刷的 3 到 7 倍。
According to Stratistics MRC, the Global Patient Monitoring Market is accounted for $42.3 billion in 2022 and is expected to reach $71.33 billion by 2028 growing at a CAGR of 9.1% during the forecast period. A patient monitoring system is a collection of tools that allow medical personnel to keep tabs on a patient's wellbeing. These devices, which are also known as remote physiologic monitoring, are frequently employed for remote patient monitoring. It is a group of devices or pieces of machinery used to track and record changes in patients' welfare while continuously monitoring them using a variety of vital signs and warning systems. Patients don't need to see a doctor as frequently, which saves money on its own. It enables appropriate adjustments to the patient's care plan and enhances data-driven clinical decision making.
According to the World Health Organization (WHO), about 422 million people globally have diabetes and around 235 million people suffer from asthma.
For governments all across the world, the sustainability of the existing healthcare system is a major issue of concern. The emphasis is now on alternate treatment modalities like home healthcare because of the growing healthcare costs, particularly in hospital settings. The usage of remote and home monitoring devices has increased, which has resulted in a significant reduction in hospital readmissions. An increase in the need for effective home-use technology, such as fetal and neonatal monitors, temperature monitors, pulse oximeters, EEG recorders, and event and ECG monitors, is accelerating the market demand.
A few of the international efforts being made to lower healthcare costs include price regulations, competitive pricing, bidding and contract procedures, coverage and payment policies, comparative efficacy of medications, technology assessments, and managed-care arrangements. Taxes are predicted to push up operational expenses and adversely impact medical device businesses cash flow in the world's main healthcare markets.
Applications for wearable patient monitoring devices include continuous glucose monitoring, temperature monitoring, blood pressure monitoring, and pulse oximetry. The Internet of Things is available on newer generations of wearable technologies. Platforms for telehealth and better patient monitoring will be easier to design as wireless data transmission networks get better and are more widely available. The market demand is being propelled by the increase in wearable biosensors.
Systems might fail due to faulty hardware or inadequate planning, thus it's critical to establish methods for anticipating and resolving system failures. Risk analysis related to system failures should be viewed as essential, especially for safety-critical applications like patient monitoring devices that deal with human health. This aspect is threatening the demand of the product.
Social segregation and quarantining practices have been used all across the world during the COVID-19 pandemic. As a consequence, many individuals avoided frequent hospital visits. This highlighted the necessity of routinely checking their home's temperature and oxygen levels to keep track on their health. Wearable technology aids in the identification of many chronic illnesses by merging clinical symptoms with vital indications. As a result, the use of wearable technologies to combat COVID-19 has dramatically increased.
The blood glucose monitoring devices segment is estimated to have a lucrative growth. Blood glucose monitoring systems include self-monitoring glucose systems and continuous monitoring systems. The introduction of new products and the expanding use of blood glucose monitoring equipment in developing nations, together with the rising incidence and prevalence of diabetes, are anticipated to drive sector expansion.
The hospitals & clinics segment is anticipated to witness the fastest CAGR growth during the forecast period. A large target patient population especially in emerging economies mostly prefers hospitals and clinics. The growing volume of procedures in hospital settings, and the financial support provided by hospitals for the introduction of various technologically advanced patient monitoring device products are all factors contributing to the large share of this market.
Asia Pacific is projected to hold the largest market share during the forecast period owing to huge prevalence of infectious illnesses. This region has large geriatric population and many and favourable public and private players are making huge investments on healthcare infrastructure. In addition, the expansion of hospital infrastructure and the rise in the number of ambulatory surgery centers are anticipated to drive the APAC region market.
North America is projected to have the highest CAGR over the forecast period. In North America, the incidence and prevalence of chronic illnesses are dramatically increasing. There are significant manufacturers notably GE Healthcare, Edward Lifesciences, Masimo Corporation and Natus Medical. They are investing on R&D to build facilities for more modern patient monitoring devices. The market expansion in this area is being accelerated by the expanding population and the growing demand to save healthcare costs.
Some of the key players profiled in the Patient Monitoring Market include Abbott Laboratories, SCHILLER , Biotelemetry, Inc, Baxter International Inc, BIOTRONIK, Shenzhen Mindray Bio-Medical, Natus Medical Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Masimo Corporation, Compumedics Limited Electronics Co., Ltd, OMRON Corporation, Nonin, GE Healthcare, Johnson & Johnson, Medtronic PLC, Koninklijke Philips NV, Becton, Dickinson and Company, Smiths Medical and Philips Healthcare.
In September 2022, GE Healthcare, a leading global medical technology, diagnostics and digital solutions innovator announced the launch of its first 'Made in India', 'AI-powered' Cath lab - Optima IGS 320 to advance cardiac care in India.
In July 2022, Johnson & Johnson Consumer Health has unveiled Vivvi & Bloom, an Environmental Working Group (EWG) certified skin and hair care brand for babies and toddlers. The brand was co-created with a community called "The Village", including Millennial and Gen-Z parents as well as caregivers who gave their input about what they wanted.
In April 2022, Philips Healthcare launched the new Philips Sonicare range of electric toothbrush series that features advanced sonic technology. It provides three to seven times better plaque removal as compared to manual toothbrushes.